Percutaneous Liver Biopsy
Percutaneous Liver Biopsy is an intervention with 7 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease
Comparison of EUS-Guided Liver Biopsy With Percutaneous Liver Biopsy
EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Clinical Trials (7)
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease
Comparison of EUS-Guided Liver Biopsy With Percutaneous Liver Biopsy
EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
All 7 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 7